GlaxoSmithKline

GSK strikes $2.2bn deal to resolve legal cases in US over heartburn treatment Zantac

The British drugmaker GSK has struck an agreement to make a payment of up to $2.2bn (£1.7bn) to resolve litigation brought in the US over its heartburn treatment Zantac.The...

No posts to display